Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.
Dechaphunkul T, Ngamphaiboon N, Danchaivijitr P, Jiratrachu R, Geater SL, Pattaranutaporn P, Jiarpinitnun C, Setakornnukul J, Suktitipat B, Dechaphunkul A. Dechaphunkul T, et al. Among authors: dechaphunkul a. Am J Otolaryngol. 2022 Mar-Apr;43(2):103356. doi: 10.1016/j.amjoto.2021.103356. Epub 2021 Dec 24. Am J Otolaryngol. 2022. PMID: 34972008 Free article.
Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
Ngamphaiboon N, Dechaphunkul A, Setakornnukul J, Dechaphunkul T, Jiratrachu R, Suktitipat B, Jiarpinitnun C, Pattaranutaporn P, Danchaivijitr P. Ngamphaiboon N, et al. Among authors: dechaphunkul a, dechaphunkul t. BMC Cancer. 2020 Jun 3;20(1):518. doi: 10.1186/s12885-020-07024-8. BMC Cancer. 2020. PMID: 32493288 Free PMC article.
Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis.
Dechaphunkul A, Danchaivijitr P, Jiratrachu R, Dechaphunkul T, Sookthon C, Jiarpinitnun C, Paoin C, Setakornnukul J, Suktitipat B, Pattaranutaporn P, Ngamphaiboon N. Dechaphunkul A, et al. Among authors: dechaphunkul t. Asia Pac J Clin Oncol. 2023 Feb;19(1):51-61. doi: 10.1111/ajco.13668. Epub 2022 Apr 8. Asia Pac J Clin Oncol. 2023. PMID: 35394108
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Even C, Wang HM, Li SH, Ngan RK, Dechaphunkul A, Zhang L, Yen CJ, Chan PC, Chakrabandhu S, Ma BBY, Tanasanvimon S, Lee VHF, Lou PJ, Li Z, Spira AI, Sukari A, Guigay J, McCune S, Gonzalez-Maffe J, Szpakowski S, Yao Y, Liang H, Mataraza J, Séchaud R, Manenti L, Lim DW. Even C, et al. Among authors: dechaphunkul a. Clin Cancer Res. 2021 Dec 1;27(23):6413-6423. doi: 10.1158/1078-0432.CCR-21-0822. Epub 2021 Aug 25. Clin Cancer Res. 2021. PMID: 34433653 Clinical Trial.
45 results